The disconnect between Salesforce’s operational performance and its stock price is widening to a notable degree. Despite posting robust quarterly results and securing major government contracts for its artificial intelligence platform, the company’s shares are languishing near a 52-week low. On Wednesday, the stock closed at $176.18, a daily decline of 3.7% and just above the February low of $174.57.
This price action stands in stark contrast to the company’s financial health. For the fourth quarter of fiscal 2026, Salesforce generated revenue of $11.2 billion, a 12% year-over-year increase. Earnings per share came in at $3.81, significantly surpassing the consensus estimate of $3.05. The trailing twelve-month free cash flow reached $14.4 billion.
A key growth driver is the AI product Agentforce. Its annual recurring revenue (ARR) surged 169% to $800 million. The platform closed over 29,000 deals in the latest period, a 50% increase from the prior quarter, with more than 60% of these bookings coming from existing customers. Significant public sector adoption is fueling this expansion. The U.S. Department of Labor is now using Agentforce in its national contact center to handle 2.8 million citizen inquiries and over 9.7 million interactions across various channels. Furthermore, the Veterans Health Administration is rolling out the platform across more than 150 medical facilities.
Commercial demand is also rising. The Adecco Group recently signed a multi-year contract for unlimited access to Agentforce 360 and Data Cloud, signaling the platform’s traction beyond the public sector.
Should investors sell immediately? Or is it worth buying Salesforce?
For the full fiscal year 2026, Salesforce reported revenue of $41.5 billion, a 10% increase, while operating cash flow grew 15% to $15 billion. Looking ahead, management provided guidance for fiscal 2027 revenue between $45.8 billion and $46.2 billion, representing growth of 10% to 11%, with an expected acceleration in organic growth during the second half of the year.
Concurrently, Salesforce continues to return capital to shareholders, even as the stock price struggles. Today marks the ex-dividend date for a quarterly cash dividend of $0.44 per share, which is 5.8% higher than the year-ago payment. The payout date is set for April 23, 2026. The dividend payout ratio remains a conservative 13.9% of earnings. The company also has an active $25 billion share repurchase program, which already reduced the share count by 1.85% last year.
The remaining performance obligation, a leading indicator of future revenue, increased 14% to $72.4 billion, pointing to a solid pipeline. Yet, the stock has lost roughly 24% year-to-date and trades nearly 60% below its 52-week high of $296.05.
Wall Street analysts see substantial upside, maintaining a consensus “Buy” rating with an average price target of approximately $280. Some analysts peg the stock’s fair value around $224. This implies a potential upside of over 50% from current levels, highlighting the pronounced gap between the company’s fundamental strength and its market valuation. Whether investor sentiment will shift to reward the firm’s operational momentum remains the critical question for the coming quarters.
Ad
Salesforce Stock: Buy or Sell?! New Salesforce Analysis from April 9 delivers the answer:
The latest Salesforce figures speak for themselves: Urgent action needed for Salesforce investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 9.
Salesforce: Buy or sell? Read more here...








